Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?

To the Editor: In a recent paper, Asano et al. reported on an analysis of single nucleotide polymorphisms (SNP) of the human resistin gene (RETN) in an aged Japanese population, and suggested that rs34861192 (SNP-638G>A) and rs3745368 (3′ UTR) are significant determinants of plasma resistin [1]. We wish to report that this statement may cause readers to conclude erroneously that rs34861192, but not rs1862513 (SNP-420C>G), is a causal variant determining circulating resistin. If the functional data were to be taken into account, the interpretation of the genetic data would be different.

It appears to us that rs1862513 can still be considered to be a promising candidate for a causal variant, as evidenced from findings available to date, including their reported results [1‐5]. First, it should be noted that their conclusion was drawn entirely from statistical analyses of genetic data. These data should be interpreted with caution, since it is not possible to assess the effect of A of rs34861192 independent of G of rs1862513, due to the absence of individuals having both the A/A genotype of rs34861192 and the C/C genotype of rs1862513. Second, their conclusion was not verified by functional analyses. Of rs34861192, rs1862513 and rs3219175 (SNP-358G>A, which is in complete linkage disequilibrium [LD] with rs34861192), functional roles have been proven only for rs1862513 in vitro [2‐5].

Most crucially, when the data in Fig. 3 of Asano et al. [1] are inspected carefully, all individuals with the A/A genotype of rs34861192 also had the G/G genotype of rs1862513. There were no individuals with both the A/A genotype of rs34861192 and the C/C genotype of rs1862513. Therefore, it is not possible to assess the effect of A of rs34861192 independent of G of rs1862513. Individuals with the A/A genotype of rs34861192 and the C/C genotype of rs1862513 should have been included in the analysis in order to determine which SNP is more critical for determining circulating resistin levels. This does not appear to be feasible due to the very low frequency of individuals with the combination of these two genotypes, which may be due to limitations in genetic epidemiology because of the available sample size. In addition, rs34861192, rs1862513 and rs3219175 are all located in the same LD block, and all of these three SNPs are strongly associated with circulating resistin levels. Based on their data, rs34861192 and rs1862513 are in moderate LD (r ² = 0.47). When calculated from our previous data in 200 type 2 diabetic cases and in 200 controls [2], r ² was similar to that of Asano et al. (r ² = 0.51 and 0.57, respectively), whereas D′ was 1 in both groups. It should be pointed out that it is difficult to identify a causal variant from highly correlated SNPs by the exclusive use of statistical analyses of genetic data, in the absence of other information [6].

From the functional point of view, four previously published papers, including ours, have shown that RETN promoter activity with G of rs1862513 is higher than that with C (see Table 1 for summary) [2‐5]. Of these papers, two suggested that the effect of G of rs1862513 is independent of A of rs34861192. Using SL2 cells, we previously showed that Sp1 and Sp3 transcription factors enhance RETN promoter activity with G of rs1862513 in the absence of rs34861192 [2]. Smith et al. showed that promoter activity with G of rs1862513 is ∼300% higher than that with C of rs1862513 in 3T3-L1 adipocytes, without rs34861192 [5]. In addition, we reported that Sp1 and Sp3 transcription factors specifically bind to DNA sequences with G of rs1862513 [2]. In contrast, Azuma et al. reported that the combination of risk alleles, A of rs34861192 and G of rs1862513, showed a higher RETN promoter activity than the other combinations of these SNPs, suggesting that A of rs34861192 and G of rs1862513 may both be required for the highest activity. There have been no reports on the clear function of rs34861192 and rs3219175 to date.

It should be noted that one cannot conclude that rs1862513 is more promising than rs34861192. First, the association of plasma resistin with rs34861192 is much stronger than that for rs1862513 (1 × 10⁻⁶⁰ vs 1 × 10⁻²⁴, respectively) [1]. Given the moderate correlation between the two SNPs (r ² = 0.47), it appears likely that this association signal is driven by rs34861192. The effect of rs1862513 appears to become more evident in the presence of rs34861192, although functional data in support of this is not available at this point. Second, the association between rs1862513 and circulating resistin had been reported in Japanese and Korean individuals [1, 2, 4], but not in white individuals [7, 8]. Since rs34861192/rs3219175 are nearly monophormic (very low frequencies of risk alleles) in white individuals (dbSNP [www.​ncbi.​nlm.​nih.​gov/​snp] and dbHAPMAP [www.​hapmap.​org/​index.​html.​en]), the risk alleles of these SNPs, together with that of rs1862513, may both be required for the highest circulating resistin levels.

In summary, it should not be simply concluded that rs34861192 is a stronger candidate for determining plasma resistin concentration than rs1862513, based on the exclusive use of statistical analyses of their genetic data [1]. From the genetic point of view, it is difficult to determine which is the most promising candidate, since rs34861192, rs1862513, and rs3219175 are in the same LD block and are strongly correlated with plasma resistin, where the sample size used was limited. From the functional data available to date, a significant function has been proven only for rs1862513 [2‐5]. Therefore, at this point, it appears that rs1862513 can still be considered to be a promising candidate for a causal variant, with the possibility that a certain combination of these three SNPs, including G of rs1862513, may have the strongest activity. The function of these SNPs, including interactions between them, remains to be elucidated. Further experiments will be required to clarify these points.